New asthma drug WIN378 aims to calm lung inflammation in phase 2 trial
Disease control
Ongoing
This study tests a new medicine, WIN378, for adults with moderate or severe asthma. WIN378 blocks a protein that causes lung inflammation, which may improve asthma control. About 136 participants will receive either WIN378 or a placebo to check safety, how the drug works in the b…
Phase: PHASE2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC